Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Difu Oral Liquid is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Yaodu Zhangshu Pharmaceutical, a subsidiary of the Renhe Group. This oral liquid preparation is composed of several key botanical ingredients, including *Rehmannia glutinosa* (Dihuang), *Poria cocos* (Fuling), *Ophiopogon japonicus* (Maidong), *Polygala tenuifolia* (Yuanzhi), *Panax ginseng* (Renshen), and *Schisandra chinensis* (Wuweizi). It is designed to nourish Yin, tonify the kidney, benefit Qi, and replenish the blood. Clinically, it is indicated for the treatment of symptoms associated with a deficiency of both Qi and Yin, such as insomnia, forgetfulness, palpitations, shortness of breath, night sweats, and weakness in the waist and knees. As a complex herbal mixture, its therapeutic profile is characterized by holistic regulation of physiological functions rather than interaction with a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fufang Difu Oral Liquid.